论文部分内容阅读
目的:对应用TAC和CAF两种新辅助化疗方案对患有乳腺癌的患者实施治疗的临床效果进行研究。方法:抽取88例患有乳腺癌的患者,随机分为对照组和治疗组,平均每组44例。采用CAF方案对对照组患者实施化疗;采用TAC方案对治疗组患者实施化疗。结果:治疗组患者乳腺癌病情治疗效果明显优于对照组;症状控制时间和化疗方案实施总时间明显短于对照组;在化疗期间不良反应率明显低于对照组;对化疗方案满意度明显高于对照组。结论:应用TAC新辅助化疗方案对患有乳腺癌的患者实施治疗的临床效果非常明显。
OBJECTIVE: To study the clinical effects of two neoadjuvant chemotherapeutic regimens using TAC and CAF in the treatment of patients with breast cancer. Methods: 88 patients with breast cancer were randomly divided into control group and treatment group, with an average of 44 cases in each group. The patients in the control group were treated with chemotherapy by CAF regimen. The patients in the treatment group were treated with TAC regimen. Results: The treatment effect of breast cancer patients in the treatment group was significantly better than that of the control group. The time of symptom control and the total duration of the chemotherapy regimen were significantly shorter than those in the control group. The adverse reaction rate was significantly lower in the chemotherapy group than in the control group. In the control group. Conclusion: The clinical effect of using TAC neoadjuvant chemotherapy in the treatment of patients with breast cancer is very obvious.